Form 483

Bio-Signal Group Corp. Form 483, 2020-02-19

FDA issued a Form 483 to Bio-Signal Group Corp. on 2020-02-19 with 3 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health3 observations

Bio-Signal Group Corp. · Acton, United States · Issued February 19, 2020

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Feb 2020
21 CFR 820.198(a)

Complaints

Cited by Stephen C Smith, Crystal Nevins

19 Feb 2020
21 CFR 820.50(a)(3)

Acceptable supplier records, inadequate records

Cited by Stephen C Smith, Crystal Nevins

19 Feb 2020
21 CFR 820.90(a)

Nonconforming product control

Cited by Stephen C Smith, Crystal Nevins

Inspected site

BGBio-Signal Group Corp.Acton, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.50(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.90(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere